|
Search
Collections
Benchmarks
Upload document
Product
Omicron
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
2 indications
Indication
COVID-19
Indication
Vaccines
Clinical trial
Phase 2, Randomized, Double-blind Study to Evaluate Immunogenicity Superiority of a Booster Dose With an Omicron or a Trivalent Vaccine Compared to CoronaVac, in Adults Immunized With Different Vaccine Schedules Against SARS-CoV-2 in Chile
Status: Completed
, Estimated PCD: 2023-10-26
